Skip Navigation
Genetics Home Reference: your guide to understanding genetic conditions
http://ghr.nlm.nih.gov/     A service of the U.S. National Library of Medicine®

ERCC2

Reviewed May 2010

What is the official name of the ERCC2 gene?

The official name of this gene is “excision repair cross-complementation group 2.”

ERCC2 is the gene's official symbol. The ERCC2 gene is also known by other names, listed below.

What is the normal function of the ERCC2 gene?

The ERCC2 gene provides instructions for making a protein called XPD. This protein is an essential part (subunit) of a group of proteins known as the general transcription factor IIH (TFIIH) complex. The TFIIH complex has two major functions: it is involved in a process called gene transcription, and it helps repair damaged DNA.

Gene transcription is the first step in protein production. By controlling gene transcription, the TFIIH complex helps regulate the activity of many different genes. The XPD protein appears to stabilize the TFIIH complex. Studies suggest that the XPD protein works together with XPB, another protein in the TFIIH complex that is produced from the ERCC3 gene, to start (initiate) gene transcription.

The TFIIH complex also plays an important role in repairing damaged DNA. DNA can be damaged by ultraviolet (UV) rays from the sun and by toxic chemicals, radiation, and unstable molecules called free radicals. DNA damage occurs frequently, but normal cells are usually able to fix it before it can cause problems. One of the major mechanisms that cells use to fix DNA is known as nucleotide excision repair (NER). As part of this repair mechanism, the TFIIH complex separates the section of double-stranded DNA that surrounds the damage. The XPD protein helps with this process by acting as a helicase, which is an enzyme that attaches to particular regions of DNA and temporarily unwinds the two spiral strands. Once the damaged region has been exposed, other proteins snip out (excise) the abnormal section and replace the damaged area with the correct DNA.

How are changes in the ERCC2 gene related to health conditions?

trichothiodystrophy - caused by mutations in the ERCC2 gene

At least 20 mutations in the ERCC2 gene have been found to cause trichothiodystrophy. Mutations in this gene are the most common cause of the photosensitive form of the condition, which is characterized by an extreme sensitivity to UV rays from sunlight.

Studies suggest that the ERCC2 gene mutations responsible for trichothiodystrophy reduce the amount of functional TFIIH complex in cells. Without enough of this complex, cells cannot effectively repair DNA damage caused by UV radiation. These problems with DNA repair cause people with the photosensitive form of trichothiodystrophy to be extremely sensitive to sunlight. Other features of the condition, such as slow growth, intellectual disability, and brittle hair, probably result from problems with the transcription of genes needed for normal development before and after birth.

Unlike xeroderma pigmentosum (described below), trichothiodystrophy is not associated with an increased risk of skin cancer. Researchers are working to determine why some mutations in the ERCC2 gene affect a person's cancer risk and others do not.

xeroderma pigmentosum - caused by mutations in the ERCC2 gene

More than two dozen mutations in the ERCC2 gene have been identified in people with xeroderma pigmentosum. Mutations in this gene are the second most common cause of xeroderma pigmentosum in the United States.

The ERCC2 gene mutations responsible for xeroderma pigmentosum prevent the TFIIH complex from repairing damaged DNA effectively. As a result, abnormalities accumulate in DNA, causing cells to malfunction and eventually to become cancerous or die. These problems with DNA repair cause people with xeroderma pigmentosum to be extremely sensitive to UV rays from sunlight. When UV rays damage genes that control cell growth and division, cells can grow too fast and in an uncontrolled way. As a result, people with xeroderma pigmentosum have a greatly increased risk of developing cancer. These cancers occur most frequently in areas of the body that are exposed to the sun, such as the skin and eyes.

When xeroderma pigmentosum is caused by ERCC2 gene mutations, it is often associated with progressive neurological abnormalities. These nervous system problems include hearing loss, poor coordination, difficulty walking, movement problems, loss of intellectual function, difficulty swallowing and talking, and seizures. The neurological abnormalities are thought to result from a buildup of DNA damage, although the brain is not exposed to UV rays. Researchers suspect that other factors damage DNA in nerve cells. It is unclear why some people with xeroderma pigmentosum develop neurological abnormalities and others do not.

other disorders - caused by mutations in the ERCC2 gene

Rarely, mutations in the ERCC2 gene can cause features of both xeroderma pigmentosum and trichothiodystrophy in the same individual. This condition is known as xeroderma pigmentosum/trichothiodystrophy (XP/TTD) complex. ERCC2 gene mutations have also been identified in a few individuals with signs and symptoms of both xeroderma pigmentosum and another condition related to defective DNA repair called Cockayne syndrome. This combination of features is known as xeroderma pigmentosum/Cockayne syndrome (XP/CS) complex.

Researchers are uncertain how mutations in this single gene can cause several different disorders with a wide variety of signs and symptoms. Studies suggest that different ERCC2 gene mutations affect the stability and function of the TFIIH complex in different ways. Mutations also have varied effects on the interaction between the XPD protein and other proteins that make up the TFIIH complex. These variations may account for the different features of xeroderma pigmentosum, trichothiodystrophy, and XP/TTD and XP/CS complexes.

Where is the ERCC2 gene located?

Cytogenetic Location: 19q13.3

Molecular Location on chromosome 19: base pairs 45,351,390 to 45,370,586

The ERCC2 gene is located on the long (q) arm of chromosome 19 at position 13.3.

The ERCC2 gene is located on the long (q) arm of chromosome 19 at position 13.3.

More precisely, the ERCC2 gene is located from base pair 45,351,390 to base pair 45,370,586 on chromosome 19.

See How do geneticists indicate the location of a gene? (http://ghr.nlm.nih.gov/handbook/howgeneswork/genelocation) in the Handbook.

Where can I find additional information about ERCC2?

You and your healthcare professional may find the following resources about ERCC2 helpful.

You may also be interested in these resources, which are designed for genetics professionals and researchers.

What other names do people use for the ERCC2 gene or gene products?

  • basic transcription factor 2 80 kDa subunit
  • BTF2 p80
  • COFS2
  • CXPD
  • DNA excision repair protein ERCC-2
  • DNA repair protein complementing XP-D cells
  • EM9
  • ERCC2_HUMAN
  • excision repair cross-complementing rodent repair deficiency, complementation group 2
  • MAG
  • MGC102762
  • MGC126218
  • MGC126219
  • TFIIH
  • TFIIH 80 kDa subunit
  • TFIIH basal transcription factor complex 80 kDa subunit
  • TFIIH basal transcription factor complex helicase subunit
  • TFIIH p80
  • TTD
  • xeroderma pigmentosum complementary group D
  • xeroderma pigmentosum group D-complementing protein
  • XPD

See How are genetic conditions and genes named? (http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/naming) in the Handbook.

What glossary definitions help with understanding ERCC2?

cancer ; cell ; deficiency ; difficulty swallowing ; disability ; DNA ; DNA damage ; DNA repair ; enzyme ; free radicals ; gene ; gene transcription ; helicase ; NER ; nervous system ; neurological ; nucleotide ; nucleotide excision repair ; protein ; radiation ; RNA ; RNA polymerase ; sensitivity ; subunit ; syndrome ; toxic ; transcription ; transcription factor ; UV rays

You may find definitions for these and many other terms in the Genetics Home Reference Glossary (http://ghr.nlm.nih.gov/glossary).

References

  • Botta E, Nardo T, Broughton BC, Marinoni S, Lehmann AR, Stefanini M. Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity. Am J Hum Genet. 1998 Oct;63(4):1036-48. (http://www.ncbi.nlm.nih.gov/pubmed/9758621?dopt=Abstract)
  • Boyle J, Ueda T, Oh KS, Imoto K, Tamura D, Jagdeo J, Khan SG, Nadem C, Digiovanna JJ, Kraemer KH. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy. Hum Mutat. 2008 Oct;29(10):1194-208. doi: 10.1002/humu.20768. (http://www.ncbi.nlm.nih.gov/pubmed/18470933?dopt=Abstract)
  • Broughton BC, Berneburg M, Fawcett H, Taylor EM, Arlett CF, Nardo T, Stefanini M, Menefee E, Price VH, Queille S, Sarasin A, Bohnert E, Krutmann J, Davidson R, Kraemer KH, Lehmann AR. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet. 2001 Oct 15;10(22):2539-47. (http://www.ncbi.nlm.nih.gov/pubmed/11709541?dopt=Abstract)
  • Broughton BC, Thompson AF, Harcourt SA, Vermeulen W, Hoeijmakers JH, Botta E, Stefanini M, King MD, Weber CA, Cole J, et al. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome. Am J Hum Genet. 1995 Jan;56(1):167-74. Review. (http://www.ncbi.nlm.nih.gov/pubmed/7825573?dopt=Abstract)
  • Faghri S, Tamura D, Kraemer KH, Digiovanna JJ. Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet. 2008 Oct;45(10):609-21. doi: 10.1136/jmg.2008.058743. Epub 2008 Jun 25. Review. (http://www.ncbi.nlm.nih.gov/pubmed/18603627?dopt=Abstract)
  • Lambert WC, Gagna CE, Lambert MW. Xeroderma pigmentosum: its overlap with trichothiodystrophy, Cockayne syndrome and other progeroid syndromes. Adv Exp Med Biol. 2008;637:128-37. Review. (http://www.ncbi.nlm.nih.gov/pubmed/19181118?dopt=Abstract)
  • Lehmann AR. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev. 2001 Jan 1;15(1):15-23. Review. (http://www.ncbi.nlm.nih.gov/pubmed/11156600?dopt=Abstract)
  • NCBI Gene (http://www.ncbi.nlm.nih.gov/gene/2068)
  • Nishiwaki T, Kobayashi N, Iwamoto T, Yamamoto A, Sugiura S, Liu YC, Sarasin A, Okahashi Y, Hirano M, Ueno S, Mori T. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients. DNA Repair (Amst). 2008 Dec 1;7(12):1990-8. doi: 10.1016/j.dnarep.2008.08.009. Epub 2008 Oct 10. (http://www.ncbi.nlm.nih.gov/pubmed/18817897?dopt=Abstract)
  • Oksenych V, Coin F. The long unwinding road: XPB and XPD helicases in damaged DNA opening. Cell Cycle. 2010 Jan 1;9(1):90-6. Epub 2010 Jan 5. Review. (http://www.ncbi.nlm.nih.gov/pubmed/20016270?dopt=Abstract)
  • Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Jaspers NG, Fawcett H, Harcourt SA, Arlett CF, Lehmann AR. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8658-63. (http://www.ncbi.nlm.nih.gov/pubmed/9238033?dopt=Abstract)

 

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.

 
Reviewed: May 2010
Published: January 27, 2015